In Vitro Transformation of Mouse Bone-Marrow-Derived (B) Lymphocytes Induced by the Lipid Component of Endotoxin
AUTOR(ES)
Rosenstreich, David L.
RESUMO
An analysis of which component of lipopolysaccharide, the lipid or the polysaccharide, is mitogenic for mouse B-lymphocytes has been performed. A purified glycolipid derived from a rough mutant of Salmonella minnesota (R595) that does not contain any o-polysaccharide at all is more mitogenic than an intact lipopolysaccharide derived from a smooth strain of S. minnesota. Results using fractions produced by several different chemical modifications of whole lipopolysaccharide confirm this result. Acid hydrolysis separates lipopolysaccharide into two components. The lipid fraction is mitogenic, whereas the polysaccharide fraction is not. Those procedures which degrade or modify only the lipid moiety while preserving the antigenic integrity of the polysaccharide also destroy mitogenicity. These include alkaline hydrolysis and deacylation by a more specific treatment with potassium methylate. The lipid preparations are fully active on highly purified B-lymphocyte populations (prepared by anti-theta antiserum and complement), whereas they have no effect on highly purified T-lymphocyte populations (prepared by anti-immunoglobulin and complement). These data demonstrate that the lipid moiety of endotoxin is the B-lymphocyte mitogen, whereas the polysaccharide has no demonstrable mitogenic activity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=422863Documentos Relacionados
- Endotoxin-induced serum factor controlling differentiation of bone-marrow-derived lymphocytes.
- Idiotypic Specificity of Surface Immunoglobulin and the Maturation of Leukemic Bone-marrow-derived Lymphocytes
- Induction of Immunoglobulin M Synthesis and Secretion in Bone-Marrow-Derived Lymphocytes by Locally Concentrated Concanavalin A
- Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay.
- The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy